chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report has been received from a Health Professional concerning a 6 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The reporter reported that a child moved during the second half dose of FLUMIST quadrivalent and it went into his eye on 20-Nov-2013. The outcome of the event FLUMIST went into eye is unknown. The report was considered to be non-serious.
mild headache, itchy nose, runny eye, sneezing- nose bleed the next morning headache, sneezing was over by morning
Information has been received from a registered nurse concerning a 12 year old female with no past medical history who on approximately 10/4/06 was vaccinated, into the arm, with a 0.5ml dose of HPV vaccine. Concomitant therapy included a dose of Hep A vaccine. It was reported that the nurse rubbed the childs arm after the vaccination and the child passed out. The physician thought that it was a vasovagal reaction and revived her with ammonia. On approximately 10/04/06, the pt recovered. Additional information has been requested.
5hrs p/inject pt started running temp & feeling real bad; p/bath noticed a fine rash on abdomen & arms; has slight runny nose & cough;
Patient received Prevnar 13 in 2015.  Patient came to pharmacy expecting to receive Pneumovax 23 but received Prevnar 13 again on 8/5/19.  Patient is aware of error and understands she needs to wait to receive pneumovax 23 when her insurance will cover again.
This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red, very itchy noticeable rash on her arm), PRURITUS (red, very itchy noticeable rash on her arm) and RASH (red, very itchy noticeable rash on her arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The patient's past medical history included Scleroderma, Raynaud's syndrome and Connective tissue disorder (Interstitial). Concurrent medical conditions included Latex allergy, Dust allergy and Pollen allergy (tree). Concomitant products included METHOTREXATE, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S) and ARGININE for an unknown indication. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ERYTHEMA (red, very itchy noticeable rash on her arm), PRURITUS (red, very itchy noticeable rash on her arm) and RASH (red, very itchy noticeable rash on her arm). At the time of the report, ERYTHEMA (red, very itchy noticeable rash on her arm), PRURITUS (red, very itchy noticeable rash on her arm) and RASH (red, very itchy noticeable rash on her arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.
3 wks p/vax devel fever of 102 x 24 hrs, coughing & significant swelling between ear & chin; seen by MD treat w/APAP, ice packs & heating pad; dx parotiditis;
High pitched exhaustive crying w/first shot 30JUL90; Lasted 2 to 3 hrs; temp from 100-102; Swelling of arm;
Just made me very weak and dizzy.  I felt off for weeks after and my period was extremely heavy a few days after.
Vaccine administered to 16 year old patient in error; FDA authorized emergency use of administered vaccine for patient's 18 years and older. Patient was monitored for  15 minutes following  vaccine administration; no adverse reaction noted.
Itchy macular rash developed on posterior part of leg and buttocks starting 3 days ago worsening over the last few days.
Patient reported muscle aches that started on 01/6/2020 at 9: 00 AM.  Muscles aches completely resolved  without the use of medication. She reports feeling fine no other complaints.
Patient started experiencing lightheadedness and dizziness after pfizer covid vaccine; gave ice pack and water; checked blood pressure and pulse; it was 133/92 and pulse=95 and 131/97 and pulse=96
Patient complained to parents of being itchy on the night of vaccine administration.  The day after administration, patient still complained of itching and mom noted hives all over.  Mom has been instructed to give patient Benadryl.  And mom was instructed to watch for any new or changing symptoms, and if so take patient to ER.
About 12 hours after receiving my 2nd shot I had a normal immune response, low grade fever around 100 degrees, achy, burning eyes.  By the next morning I felt better.  That evening around 6 pm I couldn't hear.  I went to bed around 9pm and when I woke up the morning of June 3rd I could not hear normal speech.  I called my ENT and went into his office on June 4th at 2pm.  A hearing test was conducted and I had a 30 decibel hearing loss in my right ear.  My ENT  started steriod injections behind my ear drum.  I went back in on June 7, 11 and the 14th for additional steriod injections.  Currently, my hearing is better but still compromised.  I am going in for a hearing test on Friday June 18th.
Fever; loss of appetite; No other symptoms other than loss of appetite and weariness.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old patient of unknown gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 10:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient had no reported allergies to medication, food or other products but could be sensitive to drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00 the patient experienced fever that lasted until early morning of 05Apr2021. Fever ran as high as 102 degrees Fahrenheit, never dropping below 101 through 04Apr2021. No other symptoms other than loss of appetite and weariness were reported. The events resulted in doctor or other healthcare professional office/clinic visit. On 05Apr2021, the patient underwent lab tests which included nasal swab and the result was negative. No therapeutic measures were taken as a result of the events. The clinical outcome of the event fever was recovered on 05Apr2021 while the events loss of appetite and weariness were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
A report received from a health care professional on 11/18/02, concerning a 50 year old female vaccinee who experienced an injection site reaction after receiving Fluvirin on 10/22/02. On 10/22/02, the vaccinee experienced an injection site reaction after receiving Fluvirin on the same day. Symptoms included a 2-3 inch area of redness, swelling and warmth at the site of injection. The vaccinee was treated with diphenhydramine cream for 1 day, and the event resolved after one week. There was insufficient information to determine the reporter's causality assessment.
had a sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix at the end of October and had a sore arm that resolved quickly.   No lot number or expiration date for either vaccine was known. The reporter consented to follow up. For tolerances of 2nd dose, refer case US2021AMR022113, reported by same reporter for the same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR022113:same reporter
The patient came in to day at 8 years of age with his mother and his 2 siblings (who have similar symptoms) with complaint of an illness of 2 days duration since Saturday evening (today is Monday). Of note is the fact that the patient and his 2 siblings were all immunized for the flu on October 9 and all 3 have become ill. The patient himself received the FLUMIST vaccine. His sibling received the injectable flu vaccine. The patient is complaining of cough and congestion as well as some slightly elevated temperature at this point. The patient was previously more ill but now has improved. He still complains of "phlegm in his throat." The patient does have a history of wheezing during infancy that was treated with ALBUTEROL but according to the parents improved dramatically after a tonsillectomy. The patient appears to be in no distress. There are no meningeal signs. The patients weight is 61 pounds, temperature 99.1, pulse is 80, respiratory rate is 20, and blood sugar is 102/70. There were no meningeal signs. Tympanic permits bilaterally are normal. Examination to the nose mouth and pharynx is unremarkable. There was no adenopathy neck. Auscultation of the chest was completely clear heart sounds were normal without murmurs. Assessment URI versus viral syndrome (influenza?) Reaction to FLUMIST? Plan I reviewed symptomatic treatment in detail with the parents. Report will be submitted.
Onset of Severe stomach pain on 20Mar2021.; This is a spontaneous report from a contactable consumer reporting for herself. A 37-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6208), via an unspecified route of administration, administered in Arm Left on 18Mar2021 13:45 (vaccinated at the age of 37 years old) as single dose for covid-19 immunisation. Medical history included High blood pressure and obesity. The patient's concomitant medications were not reported. The patient experienced severe stomach pain. Onset of Severe stomach pain on 20Mar2021 13:00 and resulting in an Appendectomy on 22Mar2021. Patient visited Emergency room/department or urgent care due to event. Patient had Nasal Swab on 21Mar2021 with negative result. Outcome of event was recovering.  Follow up needed, further information was requested.
Patient received 4 month vaccines on 04/20/2017 and that night he developed fever through the evening up to 102. Fever responded to TYLENOL but has been vomiting with it. He has been more spitty than normal and had an episode of vomiting not related to the TYLENOL dose (3 episodes total, 2 w/TYLENOL). Appetite down but good urine output. No diarrhea.
Narrative:  Patient received immunization for COVID 19 but tested positive on 1/3/22 with accompanying respiratory symptoms. Was evaluated in ER and discharged home. At time of ER visit patient reported he had experienced symptoms for approximately 1.5 weeks.
This spontaneous report as received from a health professional or nurse refers to a 23 year old female patient. No medical history and concurrent conditions were reported. On an unknown date the patient was vaccinated with GARDASIL 9 (lot number and expiry date unknown) (dosing regimen and frequency unknown) intramuscularly. Concomitant therapies included LEXAPRO and MIRENA IUD. On 01-FEB-2016, the patient experienced injection site soreness. It was reported that the patient sought medical attention and no treatment was given for the event. There was no product quality complaint reported. It was reported that the therapy with GARDASIL 9 was continued. The outcome of injection site pain was reported as recovering. The relatedness of the events to the therapy with GARDASIL 9 was unknown. Additional information has been requested.
Dizziness; Nausea; This spontaneous case was received on 08-Jan-2020 from other non-health professional via Med Communications (reference number: SEQW21-00015) and concerned a female patient of unspecified age.  The patient's concurrent conditions included vertigo and Meniere's disease. The patient's concomitant medications included Melasin (fluocinolone acetonide, hydroquinone, tretinoin) for nauseas.  On 20-Sep-2020, the patient was vaccinated with Afluria Quadrivalent vaccine (influenza vaccine; dose: 0.5 ml, route of administration, anatomical location: not reported) for influenza prophylaxis. The batch number was not reported.  On an unspecified date in the middle of Sep-2020, unknown amount of time after Afluria Quadrivalent, the patient experienced inner issues, dizziness and nausea.  On an unspecified date, the patient had called her doctor, which prescribed unspecified antibiotics and antiemetics but the symptoms have not improved.  At the time of initial reporting on 08-Jan-2020, the patient had not recovered from the events. The patient reported that she was having vertigo, Meniere's disease, but the symptoms never lasted this long.  The reporter did not provide a causality assessment.   The reporter assessed the case as non-serious.  Company comment: The events of 'dizziness' and 'nausea' are assessed as related to Afluria Quadrivalent vaccine.; Sender's Comments: The events of 'dizziness' and 'nausea' are assessed as related to Afluria Quadrivalent vaccine.
Arm pain that gradually turned into body pain, joint pain, chills; Arm pain that gradually turned into body pain, joint pain, chills; Arm pain that gradually turned into body pain, joint pain, chills; Arm pain that gradually turned into body pain, joint pain, chills; This is a spontaneous report from a contactable health care professional nurse, the patient.  A 29-years-old non-pregnant female patient (nurse) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), on 29DEC2020 09:15 as a single dose for COVID-19 immunization.  Medical history included depression from an unknown date and unknown if ongoing, and Covid-19 on '17th of this month ' and unknown if ongoing. The patient had no known allergies.  Concomitant medication included venlafaxine hydrochloride (EFFEXOR), spironolactone (SPIRONOLACTONE), desogestrel, ethinylestradiol (KARIVA). No other vaccines were given within 4 weeks. Since the vaccination the patient had not been tested for COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19.  On 29Dec2020 16:30, the patient experienced Arm pain that gradually turned into body pain, joint pain, chills. The pain was so extreme. Patient had Covid on the 17th of this month and was not told that you should wait 90 days after to get the vaccine. The patient reported her response was worse than the side effects of Covid. The events result in a Physician Office Visit   The patient was treated for Arm pain that gradually turned into body pain, joint pain, chills with  Heating pads,  Ibuprofen (Manufacturer Unknown) and Tylenol alternated. The clinical outcome of arm pain that gradually turned into body pain, joint pain, chills was recovered.   Information regarding lot number has been requested.
Received DTP and IPV 24 hrs ago. Developed localized rn to DPT last night post vaccines 1 x generalized urticaria rxn.
Pfizer vaccine was taken out of cold storage 04/06/23 and is good refrigerated for 70 days. The vaccine was given 74 days after taken out of cold storage thus was given after the beyond use date. Pfizer was notified. Discussed situation with Dr. Patients who received the vaccine after the beyond use date were recommended to be revaccinated.
Patient was given Boostrix IM in left arm.  Patient called following day stating her eyes were extremely red, swollen and hurt.  She had already taken bendaryl and it seemed to subsided a little bit.
No adverse event; .5 ml dose administered in error; should have been .25 ml dose
Today, she noticed that lumps and bumps are spreading to the left side of neck and going down; A month after receiving 2nd dose, she started with lumps and bumps on her head (scalp); Dermatologist said her scalp is infected; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SKIN SWELLING (A month after receiving 2nd dose, she started with lumps and bumps on her head (scalp)), FOLLICULITIS (Dermatologist said her scalp is infected) and LOCALISED OEDEMA (Today, she noticed that lumps and bumps are spreading to the left side of neck and going down) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (chloroxylenol ingredient) since April 2021.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced SKIN SWELLING (A month after receiving 2nd dose, she started with lumps and bumps on her head (scalp)) and FOLLICULITIS (Dermatologist said her scalp is infected). On 06-May-2021, the patient experienced LOCALISED OEDEMA (Today, she noticed that lumps and bumps are spreading to the left side of neck and going down). The patient was treated with GABAPENTIN ongoing since an unknown date at an unspecified dose and frequency; RIFAMPIN ongoing since an unknown date at an unspecified dose and frequency and DEXAMETHASONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, SKIN SWELLING (A month after receiving 2nd dose, she started with lumps and bumps on her head (scalp)), FOLLICULITIS (Dermatologist said her scalp is infected) and LOCALISED OEDEMA (Today, she noticed that lumps and bumps are spreading to the left side of neck and going down) outcome was unknown. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Allergy test: abnormal (abnormal) Found out that she is allergic to chloroxylenol ingredient.. In April 2021, Biopsy: abnormal (abnormal) Her scalp is infected.         Concomitant medication list was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up information received on 06-May-2021 contains non-significant information.
Per the patient's description, about 36 hours after the first dose he began having pain and tingling sensation and feeling of swelling in both feet and less in both hands. He had difficulty walking for about 2 days. No fever or anything else.  After the second dose given on January 5, 2021, Lot number EL1284, he had a milder reaction that lasted for one day and started 2 days after the shot.
I experienced fatigue. I had a phantom smell since when I had caught covid before the vaccine. I experienced tiredness and bone and joint pain in my feet. My doctor told me to add magnesium to my diet for it, and it has helped with the pain in my feet. I was sleeping for 12 hours all the way through about September 2021. I still have fatigue but its not as sever as it was the first 6 weeks  since getting the vaccine. My tissue is prone to bleed more. My allergies has gotten worse. I found out I had a heart murmur On July 28th. I saw the cardiologist on August 16th and had an EKG done. I had an echo sonogram on August 21st . I get tired and sleepy more. The tooth behind the one I injured awhile ago, tooth 30, the tooth was in perfect health. On September 4th my gum was sore, and there was an abscess on my gum. The bone had absorbed between the root of the tooth when I had seen my endodontist on 9/8/2021. I had the tooth extracted 9/10/2021 by the oral surgeon.
This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (experienced symptoms) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced vaccination complication (experienced symptoms). At the time of the report, vaccination complication (experienced symptoms) outcome: unknown. Diagnostic results: On an unknown date, SARS-CoV-2 test: positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
was given an expired dose; 2nd dose beyond the 6-12 month; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 64-year-old female patient who received HAV (Havrix adult) (batch number 7YA99, expiry date 30th September 2022) for prophylaxis.   Previously administered products included Havrix adult (1st dose received on 20th March 2020).   On 12th October 2022, the patient received the 2nd dose of Havrix adult 1 ml. On 12th October 2022, unknown after receiving Havrix adult, the patient experienced expired vaccine used and drug dose administration interval too long. On an unknown date, the outcome of the expired vaccine used and drug dose administration interval too long were unknown.   Additional Information: GSK Receipt Date: 12-OCT-2022 Reporter's Comments: The caller was a nurse reporting that a patient was given an expired dose of Havrix today.  The reporter also states that the patient got their first dose of Havrix March 2020 and so the second dose they got today was beyond the 6-12 month recommended second dosing schedule. The reporter did not consent to follow up. Additional Supportive Information: The patient received an expired dose of Havrix, which led to expired vaccine used. The patient received 2nd dose of  Havrix later than the recommended interval, which led to lengthening of the vaccine schedule.
approx 15mos p/vax pt devel shingles. pt had vesicular lesions, slight itchiness & pain. treated w/zovirax. pt had no history of chickenpox
fever, chills, itching on arms & body muscle soreness, weakness x1wk-persisting;
NAME, mother of patient, called to report that pt. had a seizure on Sunday morning 12/12/21 in which their PCP believes to be related to the second dose Pfizer pediatric vaccine that pt. recieved on Saturday 12/11/21 at a clinic held at a vaccination Center. Pt has no prior history of seizures and did not have any problems from the first dose administered on 11/20/21. Mother describes the seizure as a full tonic clonic seizure that lasted about 5 minutes. Pt.'s vitals were all normal by the time EMS arrived and the seizure had stopped. No last effects post-seizures were reported by mother.
Information has been received from a nurse concerning her 13 year old female daughter with no pertinent medical history and no known drug reactions or allergies who in February 2008, was vaccinated with the first dose of GARDASIL vaccine, IM. On an unspecified date, the patient received the second dose of GARDASIL vaccine, IM. There were no concomitant medications. The nurse reported that her daughter experienced soreness of the arm after receiving the first  and second dose of GARDASIL vaccine. The daughter recovered about 1-2 days after each vaccination. On 16-OCT-2008, the patient received the third dose of GARDASIL vaccine, IM at the tendon or joint on the arm. She was not able to lift her arm despite using ice and MOTRIM from 16-OCT-2008 for a few days. She is recovering and can move the arm now. But she is still experiencing soreness. the patient sought medical attention and consulted with the nurse's husband who is a physician. There were no lab or diagnostic studies performed. This is one of several reports from the same source. Additional information has been requested.